Cargando…

Glyceric Prodrug of Ursodeoxycholic Acid (UDCA): Novozym 435-Catalyzed Synthesis of UDCA-Monoglyceride

Bile acids (BAs) are a family of steroids synthesized from cholesterol in the liver. Among bile acids, ursodeoxycholic acid (UDCA) is the drug of choice for treating primary biliary cirrhosis and dissolving cholesterol gallstones. The clinical effectiveness of UDCA includes its choleretic activity,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zappaterra, Federico, Costa, Stefania, Summa, Daniela, Semeraro, Bruno, Cristofori, Virginia, Trapella, Claudio, Tamburini, Elena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513054/ https://www.ncbi.nlm.nih.gov/pubmed/34641510 http://dx.doi.org/10.3390/molecules26195966

Ejemplares similares

Differential effects of norUDCA and UDCA in obstructive cholestasis in mice
por: Fickert, Peter, et al.
Publicado: (2013)

Latest development in the synthesis of ursodeoxycholic acid (UDCA): a critical review
por: Tonin, Fabio, et al.
Publicado: (2018)

Pretreatment with Ursodeoxycholic Acid (UDCA) as a Novel Pharmacological Intervention in Hepatobiliary Scintigraphy
por: Jeong, Hwan-Jeong, et al.
Publicado: (2005)

Waking Action of Ursodeoxycholic Acid (UDCA) Involves Histamine and GABA(A) Receptor Block
por: Yanovsky, Yevgenij, et al.
Publicado: (2012)

Xylitol as a Hydrophilization Moiety for a Biocatalytically Synthesized Ibuprofen Prodrug
por: Zappaterra, Federico, et al.
Publicado: (2022)

Ursodeoxycholic Acid (UDCA) Exerts Anti-Atherogenic Effects by Inhibiting RAGE Signaling in Diabetic Atherosclerosis
por: Chung, Jihwa, et al.
Publicado: (2016)

Ursodeoxycholic Acid (UDCA) Exerts Anti-Atherogenic Effects by Inhibiting Endoplasmic Reticulum (ER) Stress Induced by Disturbed Flow
por: Chung, Jihwa, et al.
Publicado: (2015)

Effect of Alcohol Structure on the Optimum Condition for Novozym 435-Catalyzed Synthesis of Adipate Esters
por: Abdul Rahman, Mohd Basyaruddin, et al.
Publicado: (2011)

Biosysthesis of Corn Starch Palmitate by Lipase Novozym 435
por: Xin, Jia-Ying, et al.
Publicado: (2012)

UDCA in UC: A true disease modifier or symptoms reliever?
por: Sulais, Eman Al
Publicado: (2021)

Combination therapy of fenofibrate and ursodeoxycholic acid in patients with primary biliary cirrhosis who respond incompletely to UDCA monotherapy: a meta-analysis
por: Zhang, Yan, et al.
Publicado: (2015)

Novozym 435-Catalyzed Synthesis of Well-Defined Hyperbranched Aliphatic Poly(β-thioether ester)
por: Wu, Wan-Xia, et al.
Publicado: (2020)

Repurposing UDCA, an FXR Inhibitor, to Prevent SARS-Cov-2 Infection
por: Prayitno, Khairunnadiya, et al.
Publicado: (2023)

UDCA, a novel strategy for preventing SARS-CoV-2 infection via FXR-mediated ACE2 downregulation: UDCA and SARS-CoV-2 infection
por: Chen, Mengjiao, et al.
Publicado: (2023)

High Enantioselective Novozym 435-Catalyzed Esterification of (R,S)-Flurbiprofen Monitored with a Chiral Stationary Phase
por: Siódmiak, Tomasz, et al.
Publicado: (2015)

Rutin derivatives obtained by transesterification reactions catalyzed by Novozym 435: Antioxidant properties and absence of toxicity in mammalian cells
por: Mecenas, Anete Souza, et al.
Publicado: (2018)

External Validation of UDCA Response Score in Slovak and Croatian Patients with Primary Biliary Cholangitis
por: Gazda, Jakub, et al.
Publicado: (2021)

Gut Microbial Profile Changes in Patients with Gallbladder Stones after UDCA/CDCA Treatment
por: Lee, Jungnam, et al.
Publicado: (2023)

Microwave-Assisted Synthesis of 5′-O-methacryloylcytidine Using the Immobilized Lipase Novozym 435
por: Chea, Sany, et al.
Publicado: (2022)

Highly efficient preparation of 1-lysophosphatidylcholine via high proportion of Novozym® 435 (lipase B from Candida antarctica)-catalyzed ethanolysis
por: Yasuda, Sayumi, et al.
Publicado: (2020)

NCX 1000 Alone or in Combination with Vitamin E Reverses Experimental Nonalcoholic Steatohepatitis in the Rat Similarly to UDCA
por: Haddad, Yara, et al.
Publicado: (2011)

A network meta-analysis of the efficacy and side effects of udca-based therapies for primary sclerosing cholangitis
por: Zhu, Gui-Qi, et al.
Publicado: (2015)

Preclinical Evaluation of UDCA-Containing Oral Formulation in Mice for the Treatment of Wet Age-Related Macular Degeneration
por: Maharjan, Pooja, et al.
Publicado: (2019)

The relationship between disease activity and UDCA response criteria in primary biliary cholangitis: A cohort study
por: Jones, David E.J., et al.
Publicado: (2022)

Network Meta-Analysis of Randomized Controlled Trials: Efficacy and Safety of UDCA-Based Therapies in Primary Biliary Cirrhosis
por: Zhu, Gui-Qi, et al.
Publicado: (2015)

Bivalent Ligand UDCA-LPE Inhibits Pro-Fibrogenic Integrin Signalling by Inducing Lipid Raft-Mediated Internalization
por: Su, Jie, et al.
Publicado: (2018)

Novel Glucosylimidazolium Ionic‐Liquid‐Supported Novozym 435 Catalysts – A Proof of Concept for an Acrylation Reaction
por: Lehmann, Paul, et al.
Publicado: (2022)

Δ1-Dehydrogenation and C20 Reduction of Cortisone and Hydrocortisone Catalyzed by Rhodococcus Strains
por: Costa, Stefania, et al.
Publicado: (2020)

Perinatal exposure to UDCA prevents neonatal cholestasis in Cyp2c70(-/-) mice with human-like bile acids
por: de Vries, Hilde D., et al.
Publicado: (2022)

High Yield of Wax Ester Synthesized from Cetyl Alcohol and Octanoic Acid by Lipozyme RMIM and Novozym 435
por: Kuo, Chia-Hung, et al.
Publicado: (2012)

A multicenter, randomized, double-blind trial comparing the efficacy and safety of TUDCA and UDCA in Chinese patients with primary biliary cholangitis
por: Ma, Hong, et al.
Publicado: (2016)

Combinatorial therapy with BAR502 and UDCA resets FXR and GPBAR1 signaling and reverses liver histopathology in a model of NASH
por: Marchianò, Silvia, et al.
Publicado: (2023)

NorUDCA promotes degradation of α1-antitrypsin mutant Z protein by inducing autophagy through AMPK/ULK1 pathway
por: Tang, Youcai, et al.
Publicado: (2018)

Evidence for functional selectivity in TUDC- and norUDCA-induced signal transduction via α(5)β(1) integrin towards choleresis
por: Bonus, Michele, et al.
Publicado: (2020)

UDCA Inhibits Hypoxic Hepatocellular Carcinoma Cell–Induced Angiogenesis Through Suppressing HIF-1α/VEGF/IL-8 Intercellular Signaling
por: Lin, Wanfu, et al.
Publicado: (2021)

Biocatalytic Approach for Direct Esterification of Ibuprofen with Sorbitol in Biphasic Media
por: Zappaterra, Federico, et al.
Publicado: (2021)

Increased Selectivity of Novozym 435 in the Asymmetric Hydrolysis of a Substrate with High Hydrophobicity Through the Use of Deep Eutectic Solvents and High Substrate Concentrations
por: Fredes, Yerko, et al.
Publicado: (2019)

U12, a UDCA Derivative, Acts as an Anti-Hepatoma Drug Lead and Inhibits the mTOR/S6K1 and Cyclin/CDK Complex Pathways
por: Xu, Yang, et al.
Publicado: (2014)

The Bile Acid-Phospholipid Conjugate Ursodeoxycholyl-Lysophosphatidylethanolamide (UDCA-LPE) Disintegrates the Lipid Backbone of Raft Plasma Membrane Domains by the Removal of the Membrane Phospholipase A2
por: Stremmel, Wolfgang, et al.
Publicado: (2019)

Dihydroartemisinin-Ursodeoxycholic Bile Acid Hybrids in the Fight against SARS-CoV-2
por: Marchesi, Elena, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_herqgnj2sj85l0it7vccd98v92